Repro Med Systems, Inc. (NASDAQ:KRMD) Q4 2020 Results Conference Call March 23, 2021 4:30 PM ET Company Participants Greg Chodaczek - Senior Vice President, The Equity Group, Inc. Jim Beck - Interim CEO Linda Tharby - President & Chief Executive Officer Karen Fisher - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Kyle Rose - Canaccord Matthew O'Brien - Piper Jaffray Operator Greetings and welcome to the KORU Medical Systems Fourth Quarter 2020 Earnings Conferen ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) (State or Other Jurisdiction of Incorporation or Organization) (IRS Employer Identification No.) ...

NASDAQ: KRMD New Life, New Beginnings KORU | TM Investor Presentation November 2020 NASDAQ: KRMD FORWARD-LOOKING STATEMENTS / NON-GAAP MEASURES This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as : "expect," "plan," "goals," "believe," "intend," "see," "could," "should," and similar references to future periods. Examples of forward-l ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2020 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Commission File Number: 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) New York 13-30448 ...

NASDAQ: KRMD New Life, New Beginnings KORU | TM Q3 2020 Financial Results November 4, 2020 NASDAQ: KRMD FORWARD-LOOKING STATEMENTS / NON-GAAP MEASURES This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as : "expect," "plan," "goals," "believe," "intend," "see," "could," "should," and similar references to future periods. Examples of fo ...

Repro Med Systems, Inc. (NASDAQ:KRMD) Q3 2020 Earnings Conference Call November 4, 2020 9:00 AM ET Company Participants Devin Sullivan - Senior Vice President, The Equity Group, Inc. Donald Pettigrew - President and Chief Executive Officer Karen Fisher - Chief Financial Officer Conference Call Participants Alexander Nowak - Craig-Hallum Capital Group LLC Matthew O'Brien - Piper Sandler & Co. Kyle Rose - Canaccord Genuity Group Inc. Raghuram Selvaraju - H.C. Wainwright & Co. Alex Silverman - AWM Investment C ...

Repro Med Systems, Inc. (NASDAQ:KRMD) Q2 2020 Earnings Conference Call August 5, 2020 9:00 AM ET Company Participants Devin Sullivan - Senior Vice President, Equity Group Don Pettigrew - President and Chief Executive Officer Karen Fisher - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Matthew O'Brien - Piper Sandler Kyle Rose - Canaccord Genuity Operator Greetings and welcome to the KORU Medical's Systems Second Quarter 2020 Financial Results Conference Call. [ ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2020 Or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) Commission File Number: 0-12305 New York 13-3044880 (S ...

Repro Med Systems, Inc. (NASDAQ:KRMD) Q1 2020 Earnings Conference Call May 5, 2020 9:00 AM ET Company Participants Devin Sullivan - SVP, Equity Group Don Pettigrew - President & CEO Karen Fisher - CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Operator Greetings and welcome to the KORU Medical Systems reports First Quarter 2020 Financial Results. [Operator Instructions]. I would now like to turn the conference over to your host, Devin Sullivan, Senior Vice President of Equity Group ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2020 or [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________. Commission File Number: 0-12305 REPRO MED SYSTEMS, INC. (Exact name of registrant as specified in its charter) New York 13-3044880 ( ...